Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness
- PMID: 26852095
- DOI: 10.1016/j.jad.2016.01.041
Patients with a preference for medication do equally well in mindfulness-based cognitive therapy for recurrent depression as those preferring mindfulness
Abstract
Background: Previous studies have suggested that patients' treatment preferences may influence treatment outcome. The current study investigated whether preference for either mindfulness-based cognitive therapy (MBCT) or maintenance antidepressant medication (mADM) to prevent relapse in recurrent depression was associated with patients' characteristics, treatment adherence, or treatment outcome of MBCT.
Methods: The data originated from two parallel randomised controlled trials, the first comparing the combination of MBCT and mADM to MBCT in patients preferring MBCT (n=249), the second comparing the combination to mADM alone in patients preferring mADM (n=68). Patients' characteristics were compared across the trials (n=317). Subsequently, adherence and clinical outcomes were compared for patients who all received the combination (n=154).
Results: Patients with a preference for mADM reported more previous depressive episodes and higher levels of mindfulness at baseline. Preference did not affect adherence to either MBCT or mADM. With regard to treatment outcome of MBCT added to mADM, preference was not associated with relapse/recurrence (χ(2)=0.07; p=.80), severity of (residual) depressive symptoms during the 15-month follow-up period (β=-0.08, p=.49), or quality of life.
Limitations: The group preferring mADM was relatively small. The influence of preferences on outcome may have been limited in the current study because both preference groups received both interventions.
Conclusions: The fact that patients with a preference for medication did equally well as those with a preference for mindfulness supports the applicability of MBCT for recurrent depression. Future studies of MBCT should include measures of preferences to increase knowledge in this area.
Keywords: Antidepressant medication; Depression; Mindfulness-based cognitive therapy; Relapse prevention; Treatment preference.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial.J Affect Disord. 2015 Nov 15;187:54-61. doi: 10.1016/j.jad.2015.08.023. Epub 2015 Aug 18. J Affect Disord. 2015. PMID: 26318271 Clinical Trial.
-
Discontinuation of antidepressant medication after mindfulness-based cognitive therapy for recurrent depression: randomised controlled non-inferiority trial.Br J Psychiatry. 2016 Apr;208(4):366-73. doi: 10.1192/bjp.bp.115.168971. Epub 2016 Feb 18. Br J Psychiatry. 2016. PMID: 26892847 Free PMC article. Clinical Trial.
-
Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.BMC Psychiatry. 2012 Aug 27;12:125. doi: 10.1186/1471-244X-12-125. BMC Psychiatry. 2012. PMID: 22925198 Free PMC article. Clinical Trial.
-
Mindfulness-based cognitive therapy for residual depressive symptoms and relapse prophylaxis.Curr Opin Psychiatry. 2016 Jan;29(1):7-12. doi: 10.1097/YCO.0000000000000216. Curr Opin Psychiatry. 2016. PMID: 26575299 Free PMC article. Review.
-
[Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].Encephale. 2017 Dec;43(6):594-599. doi: 10.1016/j.encep.2016.10.004. Epub 2016 Nov 22. Encephale. 2017. PMID: 27887679 Review. French.
Cited by
-
Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.Can J Psychiatry. 2020 Aug;65(8):568-576. doi: 10.1177/0706743720904613. Epub 2020 Feb 7. Can J Psychiatry. 2020. PMID: 32031000 Free PMC article.
-
Managing Antidepressant Discontinuation: A Systematic Review.Ann Fam Med. 2019 Jan;17(1):52-60. doi: 10.1370/afm.2336. Ann Fam Med. 2019. PMID: 30670397 Free PMC article.
-
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial.Am J Psychiatry. 2022 Dec 1;179(12):959-968. doi: 10.1176/appi.ajp.20220216. Epub 2022 Sep 21. Am J Psychiatry. 2022. PMID: 36128684 Free PMC article. Clinical Trial.
-
Mindfulness and Academic Performance of College and University Students: A Systematic Review.Adv Exp Med Biol. 2023;1425:207-215. doi: 10.1007/978-3-031-31986-0_20. Adv Exp Med Biol. 2023. PMID: 37581795
-
Mental Health Conditions Among Community College Students: A National Study of Prevalence and Use of Treatment Services.Psychiatr Serv. 2021 Oct 1;72(10):1126-1133. doi: 10.1176/appi.ps.202000437. Epub 2021 Mar 4. Psychiatr Serv. 2021. PMID: 33657842 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources